“…There is growing evidence that the integrity of the nucleus (Lammerding et al, 2004;Lammerding et al, 2005;Hale et al, 2008) and mechanotransduction signaling (Lammerding et al, 2005;Emerson et al, 2009) might be impaired in the diseases linked to mutations in A-type lamins and lamin-associated proteins. Recent major findings from the Lammerding group show that cells and cardiac tissue from A-type lamin mutant mice have impaired nuclear translocation and downstream signaling of megakaryoblastic leukemia 1 protein (MKL1, also known as MRTF-A and MAL) (Ho et al, 2013), a transcription factor which regulates, through serum response factor (SRF), the expression of signaling molecules, transcription factors and numerous cytoskeletal components, including actin genes, nonmuscle myosins and vinculin (Schratt et al, 2002;Cen et al, 2003;Miralles et al, 2003). Deregulation of MKL1-SRF signaling is attributed to changes in actin dynamics in lamin A/C mutant mouse embryonic fibroblasts (MEFs) (Ho et al, 2013).…”